[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361737-105":59,"doc-detail-361737-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","dna-methylation-heterogeneity-correlates-with-field-cancerization-and-prognosis-in-lung-adenocarcinoma-patients","DNA methylation heterogeneity correlates with field cancerization and prognosis in lung adenocarcinoma patients","","Lung adenocarcinoma is a prevalent lung cancer subtype, yet how DNA methylation heterogeneity links tumor field cancerization and patient prognosis remains insufficiently characterized across tumor and matched non-malignant lung tissues. A cohort of 57 resectable stage I–III patients provided primary tumors, peri-tumoral tissue, and tumor-distant normal lung samples. Bisulfite sequencing with a custom methylation panel and targeted NGS identified tumor-specific differential methylation blocks, clustered tumors into two methylation subgroups with distinct malignancy features and survival implications.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/dna-methylation-heterogeneity-correlates-with-field-cancerization-and-prognosis-in-lung-adenocarcinoma-patients/361737/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/dna-methylation-heterogeneity-correlates-with-field-cancerization-and-prognosis-in-lung-adenocarcinoma-patients/361737.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What clinical question does the study address?","Question",{"text":113,"@type":114},"The study examines whether DNA methylation heterogeneity correlates with field cancerization and prognosis in lung adenocarcinoma patients using matched tumor and non-malignant tissues.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were samples collected and methylation analyzed?",{"text":118,"@type":114},"Samples from 57 resectable stage I–III patients were collected as primary tumor, peri-tumoral tissue, and tumor-distant normal lung. Bisulfite sequencing with a custom methylation panel and targeted next-generation sequencing were used to profile DNA methylation and somatic variation.",{"name":120,"@type":111,"acceptedAnswer":121},"What did the results show about tumor-specific methylation patterns?",{"text":122,"@type":114},"Peri-tumoral and normal tissues showed no significantly different methylation blocks, while both differed from tumor tissues. Tumors were clustered into two methylation subgroups with distinct malignancy features, EGFR mutation patterns, and pathway enrichment, including calcium signaling and P2RX2 hypermethylation in one subgroup.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},361737,1790195998,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41,"preview_page_count":19,"preview_urls":146},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","Zhou et al. Clinical Epigenetics (2025) 17:50 [https://doi.org/10.1186/s13148-025-01845-9](https://doi.org/10.1186/s13148-025-01845-9)  \nClinical Epigenetics  \n RESEARCH Open Access  \nDNA methylation heterogeneity correlates   with field cancerization and prognosis in lung adenocarcinoma patients  \nYing Zhou1, Jing Zhang1, Yang He2, Yun Wang1, Bing Li3, Tengfei Zhu3 andYanjun Su4*  \nAbstract  \nBackground Lung adenocarcinoma (LUAD) is the most common histological subtype of lung cancer. The distinctive genetic and epigenetic modifications in tumors and paired non-malignant samples, such as adjacent peri-tumor and tumor-distant normal lung tissues, have not been adequately studied.  \nMethods We recruited 57 patients with resectable stage I-III LUAD and collected matched samples ofthe primary tumor, peri-tumoral tissues, and tumor-distant normal lung tissue. We performed bisulfite sequencing using a custom methylation panel to profile DNA methylation levels and obtained somatic variation landscape through targeted next-generation sequencing (NGS) . We attempted to identify differential methylation blocks (DMBs)  \nbetween the tumor, peri-tumor, and normal tissues.  \nResults We analyzed the DNA methylation patterns of matched tumor, peri-tumor, and normal lung tissue samples from 57 LUAD patients. No significantly different methylation blocks were found between peri-tumoral and normal tissues, while they both exhibited distinct methylation profiles compared to tumor tissues. A total of 1329 tumorspecific DMBs, which are potentially associated with aberrant gene expression in LUAD, were identified. Utilizing a consensus clustering algorithm, we classified the tumor samples into two subgroups (C1 and C2) based on distinct methylation profiles, independent of the patient’s sex, tumor stage, smoking history, and tumor cell fraction. The C2 subgroup exhibited a higher malignancy density ratio (MD ratio), suggesting a more pronounced degree of field cancerization, while the C1 subgroup was characterized by a higher frequency of EGFR mutations. The DMBs between the two subgroups were enriched in the calcium signaling pathway. Notably, P2RX2 shows significant hypermethylation in the C2 subgroup, and its low expression in the external The Cancer Genome Atlas (TCGA) cohort may correlate with reduced overall survival in LUAD patients.  \nConclusion Our findings revealed distinct methylation patterns between tumor and pre-malignant samples, such as peri-tumor and normal tissues. Moreover, our study suggests that distinct clustering based on DNA methylation may indicate different prognoses in LUAD patients.  \nKeywords Lung adenocarcinoma, DNA methylation, Field cancerization, Calcium signaling, P2RX2  \n*Correspondence: Yanjun Su [yanjunsu@yeah.net](yanjunsu@yeah.net)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.or","cbCaiirqTgziUddn","https://ap.wps.com/l/cbCaiirqTgziUddn","pdf",3284463,12,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## DNA methylation and cancer progression","[{\"question\":\"What clinical question does the study address?\",\"answer\":\"The study examines whether DNA methylation heterogeneity correlates with field cancerization and prognosis in lung adenocarcinoma patients using matched tumor and non-malignant tissues.\"},{\"question\":\"How were samples collected and methylation analyzed?\",\"answer\":\"Samples from 57 resectable stage I–III patients were collected as primary tumor, peri-tumoral tissue, and tumor-distant normal lung. Bisulfite sequencing with a custom methylation panel and targeted next-generation sequencing were used to profile DNA methylation and somatic variation.\"},{\"question\":\"What did the results show about tumor-specific methylation patterns?\",\"answer\":\"Peri-tumoral and normal tissues showed no significantly different methylation blocks, while both differed from tumor tissues. Tumors were clustered into two methylation subgroups with distinct malignancy features, EGFR mutation patterns, and pathway enrichment, including calcium signaling and P2RX2 hypermethylation in one subgroup.\"}]","DNA methylation heterogeneity correlates with field cancerization and prognosis in lung adenocarcinoma patients | PDF",1790145436,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/70f99c30d9f877d67039b77f2fd3e16a.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc7cd074e9de0c1f3e610dcc57f416b4.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/485ae6d341573bbc3a47200e71efd165.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7dd787c1f220d64d3c63bed2dd73b3d1.webp",980,1301]